001452158 000__ 04259nam\a2200541\i\4500
001452158 001__ 1452158
001452158 003__ OCoLC
001452158 005__ 20230310003343.0
001452158 006__ m\\\\\o\\d\\\\\\\\
001452158 007__ cr\cn\nnnunnun
001452158 008__ 230111s2022\\\\si\a\\\\o\\\\\000\0\eng\d
001452158 020__ $$a9789811955587$$q(electronic bk.)
001452158 020__ $$a9811955581$$q(electronic bk.)
001452158 020__ $$z9789811955570
001452158 020__ $$z9811955573
001452158 0247_ $$a10.1007/978-981-19-5558-7$$2doi
001452158 035__ $$aSP(OCoLC)1357552240
001452158 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE
001452158 049__ $$aISEA
001452158 050_4 $$aRC268.2
001452158 08204 $$a616.99/4061$$223/eng/20230111
001452158 24500 $$aHormone related cancer mechanistic and nanomedicines :$$bchallenges and prospects /$$cMahfoozur Rahman, Waleed H. Almalki, Majed Alrobaian, Sarwar Beg, Khalid S. Alharbi, editors.
001452158 264_1 $$aSingapore :$$bSpringer,$$c[2022]
001452158 264_4 $$c©2022
001452158 300__ $$a1 online resource (xiv, 347 pages) :$$billustrations
001452158 336__ $$atext$$btxt$$2rdacontent
001452158 337__ $$acomputer$$bc$$2rdamedia
001452158 338__ $$aonline resource$$bcr$$2rdacarrier
001452158 5050_ $$aChapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges -- Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment -- Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities -- Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy -- Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer -- Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor -- Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead -- Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles -- Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer -- Chapter 10. Nano-Liposomal System for Breast Cancer Therapy -- Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer -- Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia -- Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours -- Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network -- Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine -- Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment -- Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines.
001452158 506__ $$aAccess limited to authorized users.
001452158 520__ $$aThe nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles.
001452158 588__ $$aDescription based on print version record.
001452158 650_0 $$aCancer$$xEndocrine aspects.
001452158 650_0 $$aCancer$$xTreatment.
001452158 650_0 $$aNanomedicine.
001452158 655_0 $$aElectronic books.
001452158 7001_ $$aRahman, Mahfoozur,$$d1984-$$eeditor.
001452158 7001_ $$aAlmalki, Waleed H.,$$eeditor.
001452158 7001_ $$aAlrobaian, Majed,$$eeditor.
001452158 7001_ $$aBeg, Sarwar,$$d1987-$$eeditor.$$1https://isni.org/isni/0000000498787728
001452158 7001_ $$aAlharbi, Khalid S.,$$eeditor.
001452158 77608 $$iPrint version:$$tHormone related cancer mechanistic and nanomedicines.$$dSingapore : Springer Nature Singapore, 2022$$z9789811955570$$w(OCoLC)1346504344
001452158 852__ $$bebk
001452158 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-5558-7$$zOnline Access$$91397441.1
001452158 909CO $$ooai:library.usi.edu:1452158$$pGLOBAL_SET
001452158 980__ $$aBIB
001452158 980__ $$aEBOOK
001452158 982__ $$aEbook
001452158 983__ $$aOnline
001452158 994__ $$a92$$bISE